# PLOS Medicine

Source: https://onco.cc/journals/plos-medicine/  
OnCo record `plos-medicine` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A fully open-access general medical journal that favours studies with global public-health impact, including cancer epidemiology, screening and health-policy work.

## Summary

Publishes under CC BY with a mandatory data-availability policy, so cancer epidemiology, risk-prediction and health-system studies here come with the underlying data. Less clinical-trial-heavy than NEJM or Lancet; strong on low- and middle-income-country cancer burden, alcohol and obesity attributable fractions, and research-integrity commentary.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: PLoS Med
- Publisher: Public Library of Science
- Scope: general medicine
- Access: open-access

## Sources

- PLOS Medicine cancer (page moved; nearest live section): https://journals.plos.org/plosmedicine/

## Connected records

- terms: [Risk factor](https://onco.cc/terms/risk-factor/)
- key papers: [Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain](https://onco.cc/key-papers/paper-pao-egfr-t790m-acquired-resistance-plos-med-2005/), [Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial](https://onco.cc/key-papers/paper-stampede-plos-med-2022-update/), [Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis](https://onco.cc/key-papers/paper-forrest-socioeconomic-inequalities-lung-cancer-treatment-plos-med-2013/)
- people: [Gianvito Martino](https://onco.cc/people/gianvito-martino/), [James Brenton](https://onco.cc/people/james-brenton/)

---
JSON: https://onco.cc/api/v1/entities/plos-medicine.json